部落格
Повышение выживаемости | Анальный рак | рак 0 | рак 1 | рак 2 | рак 3 | рак 4
Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract
Повышение выживаемости | Рак, связанный со СПИДом | Лимфома, связанная со СПИДом | рак 0 | рак 1 | рак 2 | рак 3 | рак 4
Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract
Повышение выживаемости | Адренокортикальная карцинома | рак 0 | рак 1 | рак 2 | рак 3 | рак 4
Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract
Повышение выживаемости | Острый миелоидный лейкоз | рак 0 | рак 1 | рак 2 | рак 3 | рак 4
Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract
Повышение выживаемости | Острый лимфобластный лейкоз | Острый лимфолейкоз | рак 0 | рак 1 | рак 2 | рак 3 | рак 4
Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract
Zvyšte míru přežití | Wilmsův nádor | Fáze 0 | Fáze 1 | Fáze 2 | Fáze 3 | Fáze 4
Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract
Zvyšte míru přežití | Waldenströmova makroglobulinémie | Fáze 0 | Fáze 1 | Fáze 2 | Fáze 3 | Fáze 4
Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract
Zvyšte míru přežití | Rakovina vulvy | Fáze 0 | Fáze 1 | Fáze 2 | Fáze 3 | Fáze 4
Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract
Zvyšte míru přežití | Vaginální rakovina | Fáze 0 | Fáze 1 | Fáze 2 | Fáze 3 | Fáze 4
Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract
Zvyšte míru přežití | Děložní sarkom | Fáze 0 | Fáze 1 | Fáze 2 | Fáze 3 | Fáze 4
Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract
Zvyšte míru přežití | Děložní sarkom | Fáze 0 | Fáze 1 | Fáze 2 | Fáze 3 | Fáze 4
Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract
Zvyšte míru přežití | Rakovina uretry | Fáze 0 | Fáze 1 | Fáze 2 | Fáze 3 | Fáze 4
Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract
Zvyšte míru přežití | Nádor | Fáze 0 | Fáze 1 | Fáze 2 | Fáze 3 | Fáze 4
Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract
Zvyšte míru přežití | Rakovina štítné žlázy | Fáze 0 | Fáze 1 | Fáze 2 | Fáze 3 | Fáze 4
Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract
Zvyšte míru přežití | Thymom | Fáze 0 | Fáze 1 | Fáze 2 | Fáze 3 | Fáze 4
Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract
Zvyšte míru přežití | Rakovina hrdla | Fáze 0 | Fáze 1 | Fáze 2 | Fáze 3 | Fáze 4
Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract
Zvyšte míru přežití | Rakovina varlat | Fáze 0 | Fáze 1 | Fáze 2 | Fáze 3 | Fáze 4
Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract
Zvyšte míru přežití | T-buněčný lymfom | Fáze 0 | Fáze 1 | Fáze 2 | Fáze 3 | Fáze 4
Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract
Zvyšte míru přežití | Supratentoriální primitivní neuroektodermální nádor | Fáze 0 | Fáze 1 | Fáze 2 | Fáze 3 | Fáze 4
Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract
Zvyšte míru přežití | Spinocelulární karcinom | SCC | Epidermoidní karcinom | Epiteliom skvamózních buněk | Fáze 0 | Fáze 1 | Fáze 2 | Fáze 3 | Fáze 4
Best adjuvant (assist) for chemotherapy | 1+1>487% |Effectively improve chemotherapy effect, treatment, immunity |Reduce side effects and recurrence | Overview / Relation / Abstract / Role / Principle / Action / Mechanism / Function / Work | Abstract
- ←
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17
- 18
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34
- 35
- 36
- 37
- 38
- 39
- 40
- 41
- 42
- 43
- 44
- 45
- 46
- 47
- 48
- 49
- 50
- 51
- 52
- 53
- 54
- 55
- 56
- 57
- 58
- 59
- 60
- 61
- 62
- 63
- 64
- 65
- 66
- 67
- 68
- 69
- 70
- 71
- 72
- 73
- 74
- 75
- 76
- 77
- 78
- 79
- 80
- 81
- 82
- 83
- 84
- 85
- 86
- 87
- 88
- 89
- 90
- 91
- 92
- 93
- 94
- 95
- 96
- 97
- 98
- 99
- 100
- 101
- 102
- 103
- 104
- 105
- 106
- 107
- 108
- 109
- 110
- 111
- 112
- 113
- 114
- 115
- 116
- 117
- 118
- 119
- 120
- 121
- 122
- 123
- 124
- 125
- 126
- 127
- 128
- 129
- 130
- 131
- 132
- 133
- 134
- 135
- 136
- 137
- 138
- 139
- 140
- 141
- 142
- 143
- 144
- 145
- 146
- 147
- 148
- 149
- 150
- 151
- 152
- 153
- 154
- 155
- 156
- 157
- 158
- 159
- 160
- 161
- 162
- 163
- 164
- 165
- 166
- 167
- 168
- 169
- 170
- 171
- 172
- 173
- 174
- 175
- 176
- 177
- 178
- 179
- 180
- 181
- 182
- 183
- 184
- 185
- 186
- 187
- 188
- 189
- 190
- 191
- 192
- 193
- 194
- 195
- 196
- 197
- 198
- 199
- 200
- 201
- 202
- 203
- 204
- 205
- 206
- 207
- 208
- 209
- 210
- 211
- 212
- 213
- 214
- 215
- 216
- 217
- 218
- 219
- 220
- 221
- 222
- 223
- 224
- 225
- 226
- 227
- 228
- 229
- 230
- 231
- 232
- 233
- 234
- 235
- 236
- 237
- 238
- 239
- 240
- 241
- 242
- 243
- 244
- 245
- 246
- 247
- 248
- 249
- 250
- 251
- 252
- 253
- 254
- 255
- 256
- 257
- 258
- 259
- 260
- 261
- 262
- 263
- 264
- 265
- 266
- 267
- 268
- 269
- 270
- 271
- 272
- 273
- 274
- 275
- 276
- 277
- 278
- 279
- 280
- 281
- 282
- 283
- 284
- 285
- 286
- 287
- 288
- 289
- 290
- 291
- 292
- 293
- 294
- 295
- 296
- 297
- 298
- 299
- 300
- 301
- 302
- 303
- 304
- 305
- 306
- 307
- 308
- 309
- 310
- 311
- 312
- 313
- 314
- 315
- 316
- 317
- 318
- 319
- 320
- 321
- 322
- 323
- 324
- 325
- 326
- 327
- 328
- 329
- 330
- 331
- 332
- 333
- 334
- 335
- 336
- 337
- 338
- 339
- →